ICEES+ COVID-19 Open Infrastructure to Democratize and Accelerate Cross-Institutional Clinical Data Sharing and Research
ICEES+ COVID-19 Open Infrastructure to Democratize and Accelerate Cross-Institutional Clinical Data Sharing and Research
批准号:
10158906
负责人:
John Bernard Buse
金额:
$41.27万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-02-28
关键词:
AdoptedAdoptionAsthmaAutomobile DrivingBiologicalBloodCOVID-19COVID-19 pandemicCenter for Translational Science ActivitiesClinicalClinical DataClinical SciencesCollaborationsCommunitiesConsensusCritical CareDataData PoolingDiseaseDocumentationEnvironmental ExposureExposure toFoundationsFundingGenesGenetic DeterminismGenetic PolymorphismHealthHome environmentInfectionInfrastructureInstitutesInstitutionInterventionKnowledgeLeadLeadershipLinkLung diseasesNational Heart, Lung, and Blood InstituteNational Institute of Environmental Health SciencesNorth CarolinaObesityOxygenParticipantPathway interactionsPatientsPharmaceutical PreparationsPhenotypePositioning AttributePublicationsPublishingReadinessRegistriesResearchResearch PersonnelResearch SupportRespirationRiskScienceServicesSeverity of illnessSocietiesSpeedSystemTemperatureTestingTranslational ResearchVentilatorViralVisitWorkbasecatalystclinical data warehouseclinical infrastructureclinically relevantcohortcomorbiditycoronavirus diseasedata sharingdesignexpectationexperiencefight againstgenetic varianthigh risk populationinsightknowledge graphnovelopen dataopen sourcepandemic diseasepatient subsetsprogramsresearch studyresponsetoolweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
We propose a novel technical, regulatory, and cultural solution to support research on COVID-
19 and establish the open infrastructure required to respond to the next pandemic: ICEES+
COVID-19. The proposed work will build on the prior work that our team has been engaged with
as part of the Biomedical Data Translator program (‘Translator’), funded by the National Center
for Advancing Translational Sciences (NCATS), to research and develop the Integrated Clinical
and Environmental Exposures Service (ICEES). ICEES represents a unique, disease-agnostic
framework and approach to support open sharing of and research on sensitive patient data that
have been integrated at the patient and visit level with public exposures data. Importantly,
ICEES has been validated in the context of our initial driving use case on asthma. We will
extend this effort to instantiate an ICEES+ COVID-19 open infrastructure, focused on patients at
UNC Health who have been tested (positive or negative) for COVID-19. The proposed work will
leverage not only our prior Translator work, but also new work that our team has been engaged
with as part of the NCATS Center for Data to Health (CD2H) National Covid Cohort
Collaborative (N3C). Indeed, the North Carolina Translational and Clinical Sciences Institute
(home to UNC’s CTSA) was selected by CD2H leadership to lead the technical implementation
of significant portions of the N3C initiative. We will adopt the N3C COVID-19 consensus
phenotype for the proposed work and extend the captured data fields to include relevant data
fields that were intentionally excluded by the N3C collaborative in their effort to promote
uniformity and participation, but are available via our local clinical data warehouse, such as
temperature, oxygen saturation, isolation flags, and other potentially relevant clinical features
(e.g., blood type). We also have partnered with investigators affiliated with the Environmental
Polymorphisms Registry at the National Institute for Environmental Health Sciences and will be
exposing data on their registry participants. Our overall aims are to develop and deploy ICEES+
COVID-19, apply ICEES+ COVID-19 to support research on COVID-19, and promote
widespread use of ICEES+ COVID-19, largely through our engagement with the Translator
program, CD2H N3C, and other large-scale collaboratives. A key aspect of the proposed work is
that ICEES+COVID-19 will be open source, which will allow other institutions to rapidly adopt
our approach and expose their data for open analysis of COVID-19 data by a much larger
community. Collectively, the proposed work will catalyze efforts to respond to the COVID-19
pandemic and position society to be better prepared for the next one.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
North Carolina Translational and Clinical Sciences Institute (NC TraCS)
-
批准号:10621596
-
项目类别:
-
资助金额:$1004.21万
-
财政年份:2023
-
负责人:John Bernard Buse
-
依托单位:
CTSA Diversity Supplement - Vielot - Effectiveness of Recombinant Herpes Zoster Vaccine in Older U.S. Adults
-
批准号:10294412
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2021
-
负责人:John Bernard Buse
-
依托单位:
CAMP FHIR: Lightweight, Open-Source FHIR Conversion Software to Support EHR Data Harmonization and Research
-
批准号:10402112
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2021
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational and Clinical Science Institute (NC TraCS)
-
批准号:9986930
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2019
-
负责人:John Bernard Buse
-
依托单位:
CTSA Administrative Supplement for Quality Assurance/Quality Control Position
-
批准号:10158836
-
项目类别:
-
资助金额:$9.71万
-
财政年份:2018
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational and Clinical Science Institute (NC TraCS)
-
批准号:10407956
-
项目类别:
-
资助金额:$994.56万
-
财政年份:2018
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational and Clinical Science Institute (NC TraCS)
-
批准号:9884611
-
项目类别:
-
资助金额:$927.97万
-
财政年份:2018
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational and Clinical Science Institute (NC TraCS)
-
批准号:10585423
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2018
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational and Clinical Science Institute (NC TraCS)
-
批准号:10116521
-
项目类别:
-
资助金额:$1009.39万
-
财政年份:2018
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational & Clinical Sciences Institute (NC TraCS)
-
批准号:8743352
-
项目类别:
-
资助金额:$211.0万
-
财政年份:2013
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational & Clinical Sciences Institute (NC TraCS)
-
批准号:8875794
-
项目类别:
-
资助金额:$966.41万
-
财政年份:2013
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational & Clinical Sciences Institute (NC TraCS)
-
批准号:8743354
-
项目类别:
-
资助金额:$973.61万
-
财政年份:2013
-
负责人:John Bernard Buse
-
依托单位:
North Carolina Translational & Clinical Sciences Institute (NC TraCS)
-
批准号:8743353
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2013
-
负责人:John Bernard Buse
-
依托单位:
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD Trial
-
批准号:8827407
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2012
-
负责人:John Bernard Buse
-
依托单位:
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD Trial
-
批准号:8451276
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2012
-
负责人:John Bernard Buse
-
依托单位:
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD Trial
-
批准号:8645721
-
项目类别:
-
资助金额:$66.66万
-
财政年份:2012
-
负责人:John Bernard Buse
-
依托单位:
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD Trial
-
批准号:8339696
-
项目类别:
-
资助金额:$71.67万
-
财政年份:2012
-
负责人:John Bernard Buse
-
依托单位:
CLINICAL TRIAL: ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES TRIAL (ACCORD)
-
批准号:7716878
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:John Bernard Buse
-
依托单位:
NMR & CHEMICAL LIPID ANALYSIS IN PATIENTS WITH TYPE 2 DIABETES
-
批准号:7625633
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2006
-
负责人:John Bernard Buse
-
依托单位:
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES TRIAL (ACCORD)
-
批准号:7625673
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2006
-
负责人:John Bernard Buse
-
依托单位:
海外基金